RANI compared with KLRS: revenue, margins and what each company keeps, and the suppliers and customers both name

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

KLRSKalaris Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RANIRani Therapeutics Holdings, Inc.

KLRSKalaris Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RANI 6

—Celltrionunlistedsupplier

—Chugai Pharmaceuticalunlistedsupplier

—ProGenunlistedsupplier

—ICLunlistedsupplier

2 more · RANI chain ›

Shared 0

No disclosed counterparties: KLRS.

Only KLRS 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

RANIRani Therapeutics Holdings, Inc.

0.57▼−3.08%

Mkt cap$82.2MRevenue$2MQ2 FY26

KLRSKalaris Therapeutics, Inc.

1.99▼−1.85%

Regular sessionNov 2 '26

Mkt cap$48.3MRevenue—

Compare

Regular sessionNov 2 '26

RANIRani Therapeutics Holdings, Inc.

KLRSKalaris Therapeutics, Inc.

0.57▼−3.08%

Price

1.99▼−1.85%

$82.2M

Mkt cap

$48.3M

Q2 FY26$2M

Revenue

—

RANI0.57▼−3.08%vsKLRS1.99▼−1.85%Regular sessionNov 2 '26